InvestorsHub Logo
Followers 58
Posts 10055
Boards Moderated 1
Alias Born 09/21/2016

Re: ChrisMissing post# 359857

Tuesday, 05/10/2022 11:49:58 AM

Tuesday, May 10, 2022 11:49:58 AM

Post# of 458809
Blaracas ...

I do think the R & D day could be a significant platform.



IMO, this R&D day is code for AVXL Strategic Planning Day. This platform presents and opportunity to re-emphasize the overall AVXL management S1R MOA -CNS initiative.

We have multiple CNS indications under studies at differing stages. They are each important as CNS trials in their own rights. They will serve to deliver objective evidence and will each VERIFY the case for S1R efficacy. Additionally, AVXL is making the point for MOA VALIDATION by linked provision of objective evidence from respective Verification driven trials specific to CNS indications Validation of the S1R MOA across multiple indications.

AVXL can/will prove an important fundamental scientific connection. IMO.

Brilliant.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News